Eli Lilly And Company

Eli Lilly And Company Information

Lilly (Eli) & Co. is an American-based multinational pharma company with offices in 18 countries. Its headquarters are situated in Indianapolis, Indiana, and it sells drugs in over 125 countries. Colonel Eli Lilly was a pharmaceutical chemist and American Civil War veteran who founded this company in 1876. It is traded as LLY in the New York Stock Exchange (NYSE).

Lilly employs over 33,000 people and generated a revenue of over 22 billion USD as of 2019. The company is committed to researching and developing high-quality drugs for humankind's welfare by remaining true to its work. In 1876, this company produced the medicinal drug called quinine used in the treatment of Malaria.

Among its many commendable innovations were gelatin-coating for the capsules & pills and sugar-coated pills that make them easier to swallow. It also developed various drugs for treating syphilis, rheumatism, eczema, and psoriasis in the early 1880s. A scientific journal asserted that the Lilly operation was the largest capsule factory in the world in 1917.

In 1923, Lilly mass-produced the Insulin under the name “Iletin” used to treat diabetes in the US. Moreover, it also became the company to mass-produce Penicillin in the 1940s and started producing the Polio vaccine in the early 1950s. It acquired CoLucid in 20017 for 960mn USD and Armo Biosciences for 1.6bn USD in 2018.

Also, it purchased the Aurora Kinase A, an inhibitor developer, for 575mn USD. It acquired multiple companies for developing and researching breakthroughs. The company aims to bring life-changing research to the community while performing voluntary & philanthropist operations worldwide. Currently Eli Lilly And Company has a market cap of $561.54 Billion. It has a P.E ratio of 112.57. The shares of Eli Lilly And Company are trading at $591.6.

Organization: Eli Lilly And Company

Employees: 39000

CEO: Mr. David A. Ricks

Industry: Health Technology

Comments

Exchange-Traded Funds (ETFs) Investment strategies | Dr Shashank M Hiremath | Saturday, May 18, `24

Dear Readers & Investors, Warm greetings to all! In the world of investing, Exchange-Traded Funds (ETFs) offer a diverse range of opportunities for investors seeking exposure to various asset classes, sectors, and investment themes. As you board on your investment journey or seek to diversify your portfolio, I am excited to share some insights into some of the best quality ETFs worthy of consideration. Investment strategy: Suppose you select all the mentioned ETFs representing different sectors or asset classes, during a major market correction, you may allocate additional funds to purchase more units of each ETF, aiming to take advantage of lower prices. Data extracted, as on Saturday, 18 May, `24 NSE Symbol ETF details (from NSE website) Price SILVERBEES Nippon India Silver ETF 88.37 AUTOBEES Nippon India Nifty Auto ETF 238.40 ...

Ace Your MBA Job Interview: Mastering Placement Season with Confidence!!

Ace Your MBA Job Interview: Mastering Placement Season with Confidence!! Dear Readers, The MBA journey is a rigorous climb, culminating in the crucial placement season. Landing your dream job hinges significantly on how you navigate the job interview. For MBA students, these interviews are not just Q&A sessions ; they are opportunities to showcase leadership potential, strategic thinking, and the value you bring to an organization. This article, inspired by common interview questions, will equip you with the insights to confidently navigate your MBA job interviews and secure your desired placement. 1) Crafting Your Narrative: "Tell Me About Yourself" This seemingly simple question is your opening act. Instead of reciting your resume, tell a compelling story. MBA students should weave together their academic journey, professional experiences, and career aspirations into a narrative that highlights their growth and trajectory. Explain what sparked your initial interest ...

DeepSeek’s Disruption: Redefining the AI Landscape is a Game changer for China & the World!!

DeepSeek’s Disruption: Redefining the AI Landscape The AI industry is undergoing a seismic shift, and at the center of this transformation is DeepSeek, a trailblazing innovator challenging the status quo. While established players like OpenAI and Anthropic have dominated the field with massive investments in compute power, DeepSeek has emerged with a groundbreaking approach that is not only more efficient but also significantly more cost-effective. This disruption has the potential to reshape the AI ecosystem, democratize access to advanced AI capabilities, and even threaten the dominance of hardware giants like Nvidia. The Current Landscape: A High-Cost Game Training state-of-the-art AI models today is an exorbitantly expensive endeavor. Leading AI companies spend upwards of $100 million on compute resources alone, relying on massive data centers equipped with thousands of high-end GPUs, each costing around $40,000. This paradigm has created a high barrier to entry, limiting AI develo...

Dr Shashank M Hiremath

Search This Blog